Andrew Taylor Email & Phone Number

Andrew Taylor is an experienced financial officer, operating executive, team builder and business advisor. Strategic planner and creative problem solver with strong leadership and communication skills. Proven record in public and private entrepreneurial start-up, emerging growth and Fortune 500 companies in the US and abroad. Developed and implemented corporate strategy initiatives and led M&A activity in various settings. Negotiated and secured wide-ranging equity and debt agreements. Extensive investor relations management and wide-ranging interaction and collaboration with Boards of Directors. Leadership in the areas of IPO, SEC, SOX and other compliance matters, and financial planning & analysis. Management of multiple financial audits and tax filings. Directed treasury, risk management and IT operations.Andrew Taylor joined Orchestra BioMed (NASDAQ: OBIO) as its Chief Financial Officer in June 2023 and brings over 20 years of CFO experience with emerging growth companies, the last 15 of which were in the medical device sector. Prior to joining Orchestra BioMed, Mr. Taylor served as CFO of Motus GI Holdings, Inc. (NASDAQ: MOTS), where he helped lead the company’s 2018 IPO. Prior to Motus GI, Mr. Taylor spent 10 years as CFO and President of Avertix Medical, Inc. (f/k/a Angel Medical Systems, Inc.), where he is still a member of the Board of Directors. Prior to Avertix, he was a Practice Leader for AC Lordi Consulting (now part of BDO USA, LLP) and CFO and Corporate Director of Operations for Safe3w, Inc. (acquired by iPass). Mr. Taylor earned a high-honors MBA with a concentration in Accounting and Finance from Northeastern University and a B.A. in Political Science and Economics from McGill University.

Listed skills include Mergers And Acquisitions, Start Ups, Financial Modeling, Strategic Planning, and 23 others.